Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK

被引：0
|
作者：
Modar Khalil
Hassan W Zafar
Victoria Quarshie
Fayyaz Ahmed
机构：
[1] Hull Royal Infirmary,Specialist Registrar in Neurology
[2] Hull Royal Infirmary,Specialist Headache Nurse
[3] Consultant Neurologist,undefined
[4] Hull Royal Infirmary,undefined
来源：
The Journal of Headache and Pain | 2014年 / 15卷
关键词：
Migraine; National Health Service; Chronic Migraine; Medication Overuse; Episodic Migraine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
    Khalil, Modar
    Zafar, Hassan W.
    Quarshie, Victoria
    Ahmed, Fayyaz
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [2] Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
    Khalil, M.
    Zafar, H.
    Quarshie, V.
    Ahmed, F.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [3] EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
    M Khalil
    H Zafar
    V Quarshie
    F Ahmed
    The Journal of Headache and Pain, 2014, 15
  • [4] Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
    F Ahmed
    M Khalil
    V Quarshie
    The Journal of Headache and Pain, 2013, 14
  • [5] Hull prospective analysis of Botulinum Toxin type A (Botox) use in the treatment of chronic migraine
    Ahmed, F.
    Khalil, M.
    Quarshie, V.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [6] An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
    Fayyaz Ahmed
    Charly Gaul
    Juan Carlos García-Moncó
    Katherine Sommer
    Paolo Martelletti
    The Journal of Headache and Pain, 2019, 20
  • [7] An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
    Ahmed, Fayyaz
    Gaul, Charly
    Garcia-Monco, Juan Carlos
    Sommer, Katherine
    Martelletti, Paolo
    Afanador, Lauriaselle
    Franznick, Dana
    Asmus, Peter
    Becker, Veit
    Boeger, Andrea
    Buschmann, Dirk
    Dulcius, Andrea
    Ebke, Markus
    Engelmann, Christoph
    Eser, Anna-Katharina
    Foerster, Heike
    Freitag, Frank
    Gaul, Charly
    Gendolla, Astrid
    Gerlach, Klaus
    Gessler, Martin
    Goebel, Hartmut
    Guenther, Olaf
    Halbgewachs, Frank
    Hamacher, Juergen
    Haendel, Dorothea
    Haslbeck, Matthias
    Heinicke, Volker
    Hellwig, Bernhard
    Herbst, Heinz Peter
    Hesselbarth, Sabine
    Jaeger, Hanno
    Jansen, Jan-Peter
    Jost, Wolfgang
    Kaube, Holger
    Kirchhoefer, Ulrike
    Kiszka, Michael
    Klimpel, Lothar
    Koehler, Ulrike
    Kollewe, Katja
    Kornhuber, Anselm
    Krause, Michaela
    Krome, Kathrin
    Kukowski, Borries
    Kupsch, Andreas
    Leger, Roland
    Lux, Eberhard Albert
    Mueller, Gabriele
    Mueller-Schwefe, Gerhard
    Nautscher-Timmermann, Stephan
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1)
  • [8] Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data
    Davies, Brendan
    Gaul, Charly
    Martelletti, Paolo
    Carlos Garcia-Monco, Juan
    Brown, Stephanie
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [9] Early Wearing-Off Effect of OnabotulinumtoxinA in Chronic Migraine: A Prospective Real-Life Study
    Rodriguez-Montolio, Joana
    Navarro-Perez, Maria Pilar
    Almeida-Zurita, Monserrath
    Santos-Lasaosa, Sonia
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (16)
  • [10] Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data
    Lanteri-Minet, Michel
    Ducros, Anne
    Francois, Clement
    Olewinska, Elzbieta
    Nikodem, Mateusz
    Dupont-Benjamin, Laure
    CEPHALALGIA, 2022, 42 (14) : 1543 - 1564
12345